0000313143-12-000022.txt : 20120328
0000313143-12-000022.hdr.sgml : 20120328
20120328155419
ACCESSION NUMBER: 0000313143-12-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120326
FILED AS OF DATE: 20120328
DATE AS OF CHANGE: 20120328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gordon Mikael
CENTRAL INDEX KEY: 0001418808
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 12720644
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION INCORPORATED
STREET 2: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0305
4
2012-03-26
0
0000313143
HAEMONETICS CORP
HAE
0001418808
Gordon Mikael
400 WOOD ROAD
BRAINTREE
MA
02184
0
1
0
0
President, Global Markets
Common Stock
2012-03-26
4
S
0
890.0
70.0
D
6838.0
D
Non-Qualified Stock Option (right to buy)
52.94
2010-10-27
2016-10-27
Common Stock
19587.0
19587.0
D
Non-Qualified Stock Option (right to buy)
54.55
2009-10-22
2015-10-22
Common Stock
15247.0
15247.0
D
Non-Qualified Stock Option (right to buy)
54.99
2011-10-27
2017-10-27
Common Stock
18940.0
18940.0
D
Non-Qualified Stock Option (right to buy)
55.14
2009-01-22
2015-01-22
Common Stock
18980.0
18980.0
D
Non-Qualified Stock Option (right to buy)
61.34
2012-10-25
2018-10-25
Common Stock
17565.0
17565.0
D
Pursuant to a 10b5-1 Plan.
Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
By: Susan M. Hanlon For: Mikael Gordon
2012-03-27